hPSC disease modelling
disease phenotypes
disease severity
hPSC lines
genetic variants
Cardiac arrhythmias
Cardiac Arrhythmia Risk Assessment
contribution of individual variants
forms of arrhythmia
pathogenicity of variants
use of human pluripotent stem cells
date hPSC models of arrhythmogenic diseases
stem cell biology
individual risk stratification
respective disorders
arrhythmic disorders
inherited forms
identified mutation
primary mutation
significant conceptual changes
accurate functional assessment
candidate genetic loci
significant heritable component
genotype-phenotype relationship
panels of isogenic PSC lines
human genome sequencing projects
hPSCs
lack of appropriate controls
characteristic electrophysiological features
value
young people
leading cause of death
inherent variability
wealth of genomic data
recent advances
gene-editing
past decade
patient-specific pharmacotherapy
drug development
context
patients
adverse responses
large differences
entry
interpreting GWAS
medication
outstanding issues
unique approaches
mechanism
light
proposal
area of major
therapeutics
heart
hundreds of mutations
study
sensitivity